Cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate)

[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (11Z,14Z)-icosa-11,14-dienoate

REFJKOQDWJELKE-AKLGJIFXSA-N CHEBI:176725 0 Reactome links 1 studies

Metabolite details

Identifier: REFJKOQDWJELKE-AKLGJIFXSA-N
InChI Key: REFJKOQDWJELKE-AKLGJIFXSA-N
IUPAC name: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (11Z,14Z)-icosa-11,14-dienoate
Preferred name: Cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate)
INN name: —
Synonym: —
ChEBI: CHEBI:176725

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head

Observed in differential profiles

Control_vs_AONFH_Stage_III_IV